Clinical Trial Update: Telmisartan in Mild to Moderate Hypertensive Patients [Phase 4]

View source ↗

Summary

Clinical trial update reporting a completed Phase 4 study of telmisartan for mild to moderate hypertension, sponsored by Boehringer Ingelheim.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 4 | Status: COMPLETED